# Implantable Drug Delivery Devices Market and Forecast 2025-2033

Limited-Time Offer \[Flat 15% Discount\] [Dismiss](#)

[Skip to content](#content "Skip to content")

[Updated Data Matrix Available](https://www.ihealthcareanalyst.com/research-services/)

Market Value | Market Volume | Epidemiology | Clinical Trials | Patent Landscape | Regulatory Approvals

[Home](https://www.ihealthcareanalyst.com/) » [Reports](https://www.ihealthcareanalyst.com/shop/) » [Medical Devices](https://www.ihealthcareanalyst.com/reports/medical-devices/)

![Awaiting product image](data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7)

![Awaiting product image](https://www.ihealthcareanalyst.com/wp-content/uploads/2019/08/report-icon4-e1565791186498.png)

# Implantable Drug Delivery Devices Market by Product \[Bio-Absorbable Stents, Brachytherapy Seeds (Iodine-125, Cesium-131, Palladium-103, Iridium-192, Others), Contraceptive Devices (Intravaginal Ring, Hormonal IUD, Subdermal Contraceptive Implants), Coronary Drug Eluting Stents, Drug Infusion Pumps, Intraocular Devices\], Technology (Biodegradable Drug Delivery, Non-Biodegradable Drug Delivery), Application \[Birth Control (Contraception), Cardiovascular, Oncology, Ophthalmology, Others (Diabetes, Chronic Pain)\] and Forecast 2025-2033

$3,000.00

## Report Specifications: Market Size, Market Share, Growth Trends, Forecast, Geography

Implantable drug delivery devices serve a variety of functions, from vascular stents that preserve blood flow to electro-stimulation devices that regulate heart rhythm or block spurious signals in the brain to orthopedic devices that mechanically reinforce the spine or restore range of motion of hips and knees.

Implantable devices allow site specific drug administration and allow for sustained release of a therapeutic agents, while the key material considerations include biocompatibility, stability and durability. Higher prevalence of prostate cancer, diabetic retinopathy, chronic pain causing diseases, cardiovascular diseases, colorectal cancer, unwanted pregnancies and rapidly aging global population are the driving the global implantable drug delivery devices market.

The global implantable drug delivery devices market report provides market size estimates ($million 2023 to 2033) for key market segmented by product \[bio-absorbable stents, brachytherapy seeds (iodine-125, cesium-131, palladium-103, iridium-192, others), contraceptive devices (intravaginal ring, hormonal iud, subdermal contraceptive implants), coronary drug eluting stents, drug infusion pumps, intraocular devices\], technology (biodegradable drug delivery, non-biodegradable drug delivery), application \[birth control (contraception), cardiovascular, oncology, ophthalmology, others (diabetes, chronic pain)\], and also forecast (CAGR%, 2025 to 2033).

The global implantable drug delivery devices market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and also tracks the major competitors operating in the market and provides analysis of the company overview, financial snapshot, key products, technologies and services offered, market share analysis and recent trends in the global market.

The global implantable drug delivery devices market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

Major competitors operating in the global market for implantable drug delivery systems and included in this report are Abbott Laboratories, Inc., Allergan, Inc. (TARIS Biomedical), Bausch + Lomb, Inc., Bayer HealthCare Pharmaceuticals LLC, Boston Scientific Corporation, Elekta AB (Nucletron Operations B.V.), EyePoint Pharmaceuticals, Inc. (pSivida Corporation), Medtronic plc, and Merck & Co., Inc.

Other market players include Analogic Corp. (Oncura Partners Diagnostics), Axxia Pharmaceuticals, LLC, Becton, Dickinson and Company (C. R. Bard, Inc.), Core Oncology, Inc., Delpor, Inc., Eckert & Ziegler Bebig SA, Endo International plc (Endo Pharmaceuticals), Intarcia Therapeutics, Inc., Integra LifeSciences, J3 Bioscience, Inc., Nano Precision Medical, Pfizer, Inc. Titan Pharmaceuticals, Inc., Theragenics Corporation, Varian Medical Systems, and ViaCyte, Inc.

**DATA INCLUDED:** Implantable Drug Delivery Devices Market Size, Implantable Drug Delivery Devices Market Share, Implantable Drug Delivery Devices Market Growth Rates, Implantable Drug Delivery Devices Market Trends, and Implantable Drug Delivery Devices Market Forecast to 2033

**Market Data:**

*   Estimation Base Year: 2024
*   Historical Data Range: 2023-2024
*   Forecast Period: 2025-2033
*   Market Representation: Revenue in $million and CAGR % from 2025 to 2033
*   Regional Scope: North America, Europe, Asia Pacific, Latin America, Rest of the World (Middle East & Africa)
*   Country Scope: U.S., Canada, U.K., Germany, France, Italy, Spain, Japan, China, India, South Korea, Brazil, Mexico, South Africa, South Korea, Saudi Arabia, UAE, and other countries.
*   Report Coverage: Revenue forecasts, company market share, competitive landscape analysis, growth factors, and market trends
*   Customization Scope (15% Free): Accommodation of specific or custom requirements beyond the current report scope.

**Qualitative Analysis:**

*   Industry Overview
*   Industry Trends
*   Market Driver, Restraints, and Opportunities
*   Market Size
*   Growth Trends
*   Porter’s Five Forces Analysis
*   Market Attractiveness Matrix
*   Competitive Landscape
    *   Company Overview
    *   Financial Performance
    *   Product Portfolio
    *   Strategic Insights
    *   Recent Developments

**Quantitative Analysis:**

*   Market Size Projections: Comprehensive estimates and forecasts for all segments
*   Regional Market Analysis: Estimates and forecasts for key countries
*   Corporate Financial Performance: Analysis of company financials
*   Competitive Landscape: Market share analysis of leading companies

Choose License Type

Choose an optionSingle-user LicenseMulti-user LicenseCorporate License[Clear](#)

Implantable Drug Delivery Devices Market by Product \[Bio-Absorbable Stents, Brachytherapy Seeds (Iodine-125, Cesium-131, Palladium-103, Iridium-192, Others), Contraceptive Devices (Intravaginal Ring, Hormonal IUD, Subdermal Contraceptive Implants), Coronary Drug Eluting Stents, Drug Infusion Pumps, Intraocular Devices\], Technology (Biodegradable Drug Delivery, Non-Biodegradable Drug Delivery), Application \[Birth Control (Contraception), Cardiovascular, Oncology, Ophthalmology, Others (Diabetes, Chronic Pain)\] and Forecast 2025-2033 quantity 

Buy Report   

For inquiries regarding discounts on single or bundled report purchases, please reach out to us.

*   [Table of Contents MD](#tab-table-of-contents-md)
*   [Market Segments and Companies](#tab-market-segments-and-companies)
*   [Request ToC / Sample](#tab-request-toc-sample-pages)

1.  **Introduction**
2.  **Executive Summary**
    *   Market Size Estimation ($million, 2023-2033)
    *   Forecast Estimation ($million and CAGR%, 2025-2033)
3.  [**Research Methodology**](https://www.ihealthcareanalyst.com/research-methodology/)
4.  **Market Landscape**
    *   Market Dynamics
        *   Drivers
        *   Barriers
        *   Opportunities
    *   Market Share Analysis
        *   Companies
        *   Devices
    *   Market Trends Analysis
        *   Key success factors
        *   Market Growth Rate
    *   Market Attractiveness Analysis
    *   Market Profitability Analysis
        *   Buyer power
        *   Supplier power
        *   Barriers to entry
        *   Threat of substitute products
        *   Rivalry among firms in the industry
    *   Distribution Channels
5.  **Market Segmentation** \[_refer Market Segments and Companies Tab_\]
    *   Device or Brand Type
    *   Diagnostic Test
    *   Indication Type
    *   Technology
    *   Diagnostics, Therapeutic or Surgical Application
    *   End User Groups
6.  **Geography (Region, Country)**
    *   North America (U.S., Canada)
    *   Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    *   Asia Pacific (Japan, China, India, Rest of APAC)
    *   Latin America (Brazil, Mexico, Rest of LA)
    *   Rest of the World (Middle East & Africa)
7.  **Regulatory Overview** 
    *   Device Classification I, II, III, IV
    *   Device (FDA, EMEA) Approvals
8.  **Company Profiles** \[_refer Market Segments and Companies Tab_\]
    *   Company Overview
    *   Financial Snapshot
    *   Product Portfolio
    *   Business Strategies
    *   Recent Developments
9.  **Recommendations**
10.  **References**

**Key Questions Answered:**  
1\. What are the factors driving and limiting this market, key success factors and challenges?  
2\. Which are the leading competitors in the market, their market share, profitability and key trends by product, technology, services portfolio?  
3\. How do markets perform between countries and regions?  
4\. What market segments are contributing to maximum share and greatest growth?  
5\. What is the product or procedure volumes by country and regions?

**Actionable Insights Included:**  
1\. Product portfolio matrix (Share vs. Growth)  
2\. Market attractiveness (Region vs. Growth)  
3\. Spot matrix (Product vs. Region)  
4\. Geographic distribution matrix (Share vs. Growth)

**Implantable Drug Delivery Devices Market  
**

1\. **Product**  
1.1. Bio-Absorbable Stents  
1.2. Brachytherapy Seeds  
1.2.1. Iodine-125  
1.2.2. Cesium-131  
1.2.3. Palladium-103  
1.2.4. Iridium-192  
1.2.5. Others  
1.3. Contraceptive Devices  
1.3.1. Intravaginal Ring  
1.3.2. Hormonal IUD  
1.3.3. Subdermal Contraceptive Implants  
1.4. Coronary Drug Eluting Stents  
1.5. Drug Infusion Pumps  
1.6. Intraocular Devices

2\. **Technology**  
2.1. Biodegradable Drug Delivery  
2.2. Non-Biodegradable Drug Delivery

3\. **Application**  
3.1. Birth Control (Contraception)  
3.2. Cardiovascular  
3.3. Oncology  
3.4. Ophthalmology  
3.5. Others (Diabetes, Chronic Pain)

4\. **Geography**  
4.1. North America (U.S., Canada)  
4.2. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)  
4.3. Asia Pacific (Japan, China, India, Rest of APAC)  
4.4. Latin America (Brazil, Mexico, Rest of LA)  
4.5. Rest of the World

5\. **Company Profiles**  
5.1. Abbott Laboratories, Inc.  
5.2. Allergan, Inc. (TARIS Biomedical)  
5.3. Analogic Corp. (Oncura Partners Diagnostics)  
5.4. Axxia Pharmaceuticals, LLC  
5.5. Bausch + Lomb, Inc.  
5.6. Bayer HealthCare Pharmaceuticals LLC  
5.7. Becton, Dickinson and Company (C. R. Bard, Inc.)  
5.8. Boston Scientific Corporation  
5.9. Core Oncology, Inc.  
5.10. Delpor, Inc.  
5.11. Eckert & Ziegler Bebig SA  
5.12. Elekta AB (Nucletron Operations B.V.)  
5.13. Endo International plc (Endo Pharmaceuticals)  
5.14. EyePoint Pharmaceuticals, Inc. (pSivida Corporation)  
5.15. Intarcia Therapeutics, Inc.  
5.16. Integra LifeSciences  
5.17. J3 Bioscience, Inc.  
5.18. Medtronic plc  
5.19. Merck & Co., Inc.  
5.20. Nano Precision Medical  
5.21. Pfizer, Inc.  
5.22. Titan Pharmaceuticals, Inc.  
5.23. Theragenics Corporation  
5.24. Varian Medical Systems  
5.25. ViaCyte, Inc.

**Request Table of Contents / Sample Report**

Full Name\*

Company Email\*

Phone Number\* \[Please add country code\]

Subject\*

Message\*

Resource Links

*   [About Us](https://www.ihealthcareanalyst.com/about/)
*   [Clinical Trials](https://www.ihealthcareanalyst.com/clinical-trials-dashboard/)
*   [Drugs@FDA](https://www.ihealthcareanalyst.com/drugs-fda-dashboard/)
*   [Orange Book](https://www.ihealthcareanalyst.com/orange-book-dashboard/)
*   [Premarket Approval](https://www.ihealthcareanalyst.com/premarket-approval-pma/)
*   [Premarket Notification](https://www.ihealthcareanalyst.com/premarket-notification-510k/)
*   [Publications](https://www.ihealthcareanalyst.com/publications/)

Terms and Conditions

*   [FAQs](https://www.ihealthcareanalyst.com/faqs/)
*   [Careers](https://www.ihealthcareanalyst.com/careers/)
*   [Terms of Use](https://www.ihealthcareanalyst.com/terms/)
*   [How to Order](https://www.ihealthcareanalyst.com/order/)
*   [Return Policy](https://www.ihealthcareanalyst.com/return/)
*   [Privacy Policy](https://www.ihealthcareanalyst.com/privacy/)
*   [Disclaimer Policy](https://www.ihealthcareanalyst.com/disclaimer/)

Secure Online Payment

![iHealthcareAnalyst, Inc.](https://www.ihealthcareanalyst.com/wp-content/uploads/2018/07/creditcard-payment-logos-300x48.jpg)

Search

Search

Contact Address

**US Office:** 2109, Mckelvey Hill Drive, Maryland Heights, MO 63043, United States  
Phone: +1 (314) 315-4764  
**India Office:** 5, Shilpa Chambers, Opp. J. M. Road, Shivajinager, Pune 411005, India  
Phone: +91 (20) 25898524  
Email: [\[email protected\]](/cdn-cgi/l/email-protection#d8abb9b4bdab98b1b0bdb9b4acb0bbb9aabdb9b6b9b4a1abacf6bbb7b5)

[](# "Scroll back to top")

Search for: